Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY 4.0PLOS One

The cGAS-STING pathway in acute myocardial infarction: Biomarker discovery and mechanistic insights

  • Juying Li1
  • Hongkui Chen2
  • Yihao Huang3
  • Yupeng Zhi
  • Chun Chen
  • Yansong Guo
  1. 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China
  2. 2Department of Cardiology, The First People’s Hospital of Yibin, Yibin, Sichuan, China
  3. 3School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China
Open at sourcePDFDOICite

Abstract

Acute Myocardial infarction (AMI) continues to be a severe deadly disease with a high case-fatality rate and great psychological and economic costs. Despite the development of new therapies, early diagnosis and treatment optimization still are problematical. Here we applied the integrated bioinformatics strategy to screen potential new diagnosis biomarkers for AMI based on the inflammation-related cGAS-STING pathway. By integrating differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA), and cGAS-STING gene set from high-throughput RNA sequencing, we obtained a total of 11 candidate genes from 914 DEGs, which enriched mainly for inflammatory and immune response pathways. Further refining them in machine learning algorithms, we identified core genes with diagnostic values. Subsequent test shows the AUC values of PFKFB3 and TLR2 both were more than 0.7 and their promising diagnostic values were verified. Based on the immune infiltration analysis, expression of PFKFB3 and TLR2 were very significantly associated with a large number of immune cells, such as monocytes, neutrophils and dendritic cells. As for single cell sequencing analysis, they were mainly found expressed on macrophages. Overall, we show that PFKFB3 and TLR2 are possible biomarkers of AMI which have not been reported so far. Thus they may open a path for new diagnostics and personalized therapy. Validation in independent populations is needed.

Related

  1. Identification and validation of cholesterol homeostasis and NK cell-associated predictive and therapeutic models for Coronary atherosclerotic heart disease patients with ST-elevated myocardial infarction: Insights from artificial intelligence and multi-omics
    Xuemei Chen, Yifan Zhao, Xixi Guo +5
    Computational Biology and ChemistryPeer-reviewedCC BY-NC-ND7 citedImmunologyOpenAlex
  2. A NET-associated immunothrombotic phenotype is associated with coronary no-reflow and myocardial injury after primary PCI in ST-segment elevation myocardial infarction: a real-world translational cohort
    Zhigang Sun, Zhidong Zhang, Gang Qiao +1
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  3. From marrow memory to adverse ventricular remodeling: trained immunity after myocardial infarction
    Xuanchun Huang, Lanshuo Hu, Xinxin Shi +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Poor survival after myocardial infarction in immune deficient NXG B2m mice is alleviated by transplantation of induced pluripotent stem cell derived cardiomyocytes (iPSC-CM) formulated as spheres, but not single cells
    A. K. S. Terp, D. G. Ellman, S. B. Mathiesen +7
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  5. Re. The influence of personality on the risk of myocardial infarction in UK Biobank cohort
    Alexander Weiss
    PsyArXivPreprintCC BY 4.0Full textGeneral biologyPsychiatry & mental healthOSF

Cite

BibTeXRIS
BibTeX
@article{li2026cgassting,
  title = {{The cGAS-STING pathway in acute myocardial infarction: Biomarker discovery and mechanistic insights}},
  author = {Juying Li and Hongkui Chen and Yihao Huang and Yupeng Zhi and Chun Chen and Yansong Guo},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0355694},
  url = {https://doi.org/10.1371/journal.pone.0355694},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The cGAS-STING pathway in acute myocardial infarction: Biomarker discovery and mechanistic insights
AU  - Juying Li
AU  - Hongkui Chen
AU  - Yihao Huang
AU  - Yupeng Zhi
AU  - Chun Chen
AU  - Yansong Guo
PY  - 2026
DA  - 2026/09/18
JO  - PLOS One
DO  - 10.1371/journal.pone.0355694
UR  - https://doi.org/10.1371/journal.pone.0355694
AB  - Acute Myocardial infarction (AMI) continues to be a severe deadly disease with a high case-fatality rate and great psychological and economic costs. Despite the development of new therapies, early diagnosis and treatment optimization still are problematical. Here we applied the integrated bioinformatics strategy to screen potential new diagnosis biomarkers for AMI based on the inflammation-related cGAS-STING pathway. By integrating differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA), and cGAS-STING gene set from high-throughput RNA sequencing, we obtained a total of 11 candidate genes from 914 DEGs, which enriched mainly for inflammatory and immune response pathways. Further refining them in machine learning algorithms, we identified core genes with diagnostic values. Subsequent test shows the AUC values of PFKFB3 and TLR2 both were more than 0.7 and their promising diagnostic values were verified. Based on the immune infiltration analysis, expression of PFKFB3 and TLR2 were very significantly associated with a large number of immune cells, such as monocytes, neutrophils and dendritic cells. As for single cell sequencing analysis, they were mainly found expressed on macrophages. Overall, we show that PFKFB3 and TLR2 are possible biomarkers of AMI which have not been reported so far. Thus they may open a path for new diagnostics and personalized therapy. Validation in independent populations is needed.
SN  - 1932-6203
ER  -